January 5, 2023

Trial Results: A recent ECOG-ACRIN study finds excellent results for patients with acute lymphoblastic leukemia (ALL)

Adding immunotherapy to standard chemotherapy keeps most patients in remission and improves their survival
June 28, 2022

Now Enrolling: The EA9213 clinical trial is testing a new treatment for patients with T-cell acute lymphoblastic leukemia

This trial is for patients who have leukemia cells still in the blood or bone marrow after initial treatment
March 24, 2022

Trial Results: ECOG-ACRIN research round-up – Spring 2022

Summaries of recently reported ECOG-ACRIN research results
December 15, 2021

Trial Results: Blood cancers are the focus of recent ECOG-ACRIN research

Summaries of leukemia, lymphoma, and myeloma research results